GET THE APP

Jornal Europeu de Oncologia Clínica

ISSN - 2732-2654

Volume 6, Emitir 1 (2024)

Perspectiva

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspectiva

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspectiva

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspectiva

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspectiva

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspectiva

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspectiva

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspectiva

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspectiva

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspectiva

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

pesquisar

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

pesquisar

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

pesquisar

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

pesquisar

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

pesquisar

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Artigo de Pesquisa

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Artigo de Pesquisa

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Artigo de Pesquisa

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Artigo de Pesquisa

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Artigo de Pesquisa

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Comunicação curta

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Comunicação curta

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Comunicação curta

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Comunicação curta

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Comunicação curta

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi